Federal Register / Vol. 88, No. 172 / Thursday, September 7, 2023 / Notices 61607 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. The meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; R13 Conference 

Grant Applications. 

Date: September 28, 2023. 

Time: 10:00 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, NIDDK 

Democracy II, Suite 7000A, 6707 Democracy 

Boulevard Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Jian Yang, Ph.D., Scientific 

Review Officer, NIDDK/Scientific Review 

Branch, National Institutes of Health, 6707 

Democracy Boulevard, Room: 7111, 

Bethesda, MD 20892–2542, (301) 594–7799, 

yangj@extra.niddk.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 31, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–19263 Filed 9–6–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Risk, Prevention 

and Health Behavior Integrated Review 

Group Biobehavioral Medicine and 

Health Outcomes Study Section. 

Date: October 3–4, 2023. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II 6701 Rockledge Drive 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mark A Vosvick, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

3110, Bethesda, MD 20892 (301) 402– 

4128. mark.vosvick@nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Neuroscience 

of Basic Visual Processes, Study 

Section. 

Date: October 4–5, 2023, 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: Melrose Hotel 2430 

Pennsylvania Ave. NW, Washington, DC 

20037, 

Contact Person: Kirk Thompson, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

5184, MSC 7844 Bethesda, MD 20892 

301–435–1242 kgt@mail.nih.gov. 

Name of Committee: Brain Disorders 

and Clinical Neuroscience Integrated 

Review Group, Clinical 

Neuroimmunology and Brain Tumors 

Study Section. 

Date: October 5–6, 2023. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel 2430 

Pennsylvania Ave. NW, Washington, DC 

20037. 

Contact Person: Aleksey G Kazantsev, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

5201, Bethesda, MD 20817, 301–435– 

1042, aleksey.kazantsev@nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group, Behavioral 

Neuroendocrinology, 

Neuroimmunology, Rhythms, and Sleep 

Study Section. 

Date: October 5–6, 2023. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Michael Selmanoff, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

5164, MSC 7844, Bethesda, MD 20892, 

301–435–1119, selmanom@csr.nih.gov. 

Name of Committee: Emerging 

Technologies and Training 

Neurosciences, Integrated Review 

Group, Molecular Neurogenetics Study 

Section. 

Date: October 5–6, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Mary G Schueler, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

5214, MSC 7846, Bethesda, MD 20892, 

301–915–6301, marygs@csr.nih.gov. 

Name of Committee: Genes, Genomes, 

and Genetics Integrated Review Group 

Genomics, Computational Biology and 

Technology Study Section. 

Date: October 5–6, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Methode Bacanamwo, 

Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes 

of Health, 6701 Rockledge Drive, Room 

2200, Bethesda, MD 20892, 301–827– 

7088, methode.bacanamwo@nih.gov. 

(Catalogue of Federal Domestic 

Assistance Program Nos. 93.306, 

Comparative Medicine; 93.333, Clinical 

Research, 93.306, 93.333, 93.337, 

93.393–93.396, 93.837–93.844, 93.846– 

93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 31, 2023. 

David W Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–19282 Filed 9–6–23; 8:45 am] 

BILLING CODE 4140–01–P 


ddrumheller on DSK120RN23PROD with NOTICES1